Lithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer. [electronic resource]
Producer: 20130802Description: 361-6 p. digitalISSN:- 1525-1438
- Cell Cycle -- drug effects
- Cell Proliferation -- drug effects
- Cystadenocarcinoma, Serous -- drug therapy
- Female
- Glycogen Synthase Kinase 3 -- antagonists & inhibitors
- Glycogen Synthase Kinase 3 beta
- Humans
- Lithium Chloride -- pharmacology
- Ovarian Neoplasms -- drug therapy
- Primary Cell Culture
- Protein Kinase Inhibitors -- pharmacology
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.